SFMN
Société Française de Médecine Nucléaire

SFMN
Société Française de Médecine Nucléaire
et Imagerie Moléculaire

SFMN
Société Française de Médecine Nucléaire
et Imagerie Moléculaire

SFMN
Société Française de Médecine Nucléaire
et Imagerie Moléculaire

La TEP au 18F-FNa - VIII. REFERENCES

VIII. REFERENCES

 

Généralités

  1. SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0* Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, Smith GT J Nucl Med 2010;51:1813-20.

 

Indications oncologiques

  1. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kuhn T, Kreienberg R et al. J Clin Oncol 1999;17:2381-89.
  2. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M et al. J Nucl Med 1999;40:1623-9.
  3. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. Hetzel M, Arslandemir C, Konig HH, Buck AK, Nussle K, Glatting G, et al. J Bone Miner Res 2003;18:2206-14.
  4. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view TEMP, 18F-Fluoride PET, and 18F-Fluoride PET/CT. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. J Nucl Med 2006;47:287-97.
  5. Detection of bone metastases in patients with prostate cancer by F-18 fluorocholine and F-18 fluoride PET-CT: a comparative study. Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W et al. Eur J Nucl Med Mol Imaging 2008; 35: 1766-74.
  6. Prostate cancer: role of SPECT and PET in imaging bone metastases. Beheshti M, Langsteger W, Fogelman I. Semin Nucl Med. 2009;39:396–407.
  7. Skeletal PET with 18F-fluoride: applying new technology to an old tracer Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. J Nucl Med. 2008;49:68–78.
  8. Breast cancer: role of SPECT and PET in imaging bone metastases. Ben-Haim S, Israel O. Semin Nucl Med. 2009;39:408–415.
  9. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases. Chua S, Gnanasegaran G, Cook GJR. Semin Nucl Med. 2009;39:416–430.
  10. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Krüger S, Buck AK, Mottaghy FM, et al. Eur J Nucl Med Mol Imaging. 2009;36:1807–1812.
  11. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF, Chen CY, Cheng MF, et al. Nucl Med Commun. 2010;31:637-45.
  12. Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading. Langsteger W, Balogova S, Huchet V et al. Q J Nucl Med Mol Imaging 2011; 55: SOUS PRESSE
  13. Diagnosis of bone metastasis. Recent comparative studies of imaging modalities Talbot JN, Paycha F, Balogova S. Q J Nucl Med Mol Imaging 2011; 55: SOUS PRESSE

 

Indications non oncologiques

  1. Skeletal trauma in child abuse: detection with 18F-NaF PET. Drubach LA, Johnston PR, Newton AW, et al. Radiology. 2010; 255: 173-81.
  2. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. Lim R, Fahey FH, Drubach LA et al. J Pediatr Orthop. 2007; 27:277-82.
  3. Back pain in adolescents: assessment with integrated 18F-fluoride positron-emission tomography-computed tomography. Ovadia D, Metser U, Lievshitz G, et al. J Pediatr Orthop 2007; 27: 90-93
  4. The role of PET/CT in evaluation of facet and disc abnormalities in patients with low back pain using (18)F-Fluoride. Gamie S, El-Maghraby T. Nucl Med Rev Cent East Eur.2008; 11: 17-21.

 

Dosimétrie pédiatrique

  1. The new EANM paediatric dosage card: additional notes with respect to F-18 Lassmann F, Biassoni L, Monsieurs M, Franzius C. EANM Dosimetry and Paediatrics Committees Eur J Nucl Med Mol Imaging 2008;35:1666–68

 

 

 

Designed by SFMN - ACORAMEN